Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Performance
Open
0.53Prev. Close
0.54Volume
1,58,13,984Total traded value
0.89 CrUpper Circuit
0.56Lower Circuit
0.52Fundamentals
| Market Cap | ₹67Cr |
| ROE | 25.60% |
| P/E Ratio(TTM) | 1.93 |
| EPS(TTM) | 0.28 |
| P/B Ratio | 0.50 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.28 |
| Book Value | 1.09 |
| Debt to Equity | 0.92 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Welcure Drugs
Welcure Drugs & Pharmaceuticals operates in the pharma industry, but its business activities were closed during the year due to financial constraints. The company's philosophy focuses on enhancing investor confidence through corporate practices based on conscience, openness, fairness, and professionalism. Despite current challenges, the company maintained a significant base of 31,530 shareholders as of March 31, 2024.;
| Parent Organisation | Welcure Drugs & Pharmaceuticals Limited |
| Managing Director | Shri. Sudhir Chandra |
| BSE Symbol | 524661 |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.21 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.69 | ||
| Cohance Lifesciences | NA (0.00%) | 71.09 | ||
| Wockhardt | NA (0.00%) | -423.74 |